Friday’s extreme weakness continued into Monday as I suggested would happen late last week. There is always the possibility of a short-term reprieve with news occurring over the weekend, but that didn’t happen to put a bid under the market Monday morning. Stocks plummeted to new lows again. Where may it be headed? February lows […]
Read Article
The US equities markets were quite depressed today, with most indexes firmly lower through most of the session. The S&P 500 etf SPY was down over -1.70%, the healthcare etf XLV was down over -2%, and the biotech etf IBB was down over -1%. Concern about rising interest rates appears to be one of the […]
Read Article
Here we go again – the market is extremely weak going into the Friday close. Remember the end-of-the-week wild rallies? Yeah, good times…but they’re gone. There is no single reason why it’s lower today but there is enough general bearishness to cause it. There is turmoil in France, Brexit problems, Italy and more. Additionally, the […]
Read Article
Stocks across the globe are losing ground after weak economic data from China and Europe (see below) fanned concerns of a worldwide slowdown. Traders had anticipated a “Santa Rally” might have arrived following a rough December start for equities, but current sentiment may now signal a dead-cat bounce. On the U.S. economic calendar for today […]
Read Article
The US equities markets were bearish today overall, and two stocks in particular saw sharp declines. One stock was Johnson & Johnson (JNJ), which is obviously a major name in the healthcare sector. The company’s stock was down over -10% at one point during the session due to news that the company may have hidden […]
Read Article
Clovis Oncology (CLVS) rose in trading today due to positive news on one of its products. The company’s Rubraca product received a positive opinion from CHMP as a maintenance treatment for women with relapsed ovarian cancer. CLVS shares were up over +4% as of the time this content was created. Here is a recap of […]
Read Article
Today I talk about a stock that gets very little public hype or analyst love, yet the company has been one of the more consistent performers for the year. Take a look at what I have to say about $MSI and why I am a fan of the upside. Now certain levels have to hold […]
Read Article
In today’s video, we discuss the recent entry of a recommendation of our Momentum Stocks room. In it, I show the importance of waiting for your spots, a deep entry in this case, when the overall market is so volatile.
Read Article
The markets have been swinging back and forth to put it lightly. In today’s video, I break down what I see in the near term and which market is showing strength in the times of weakness. There are positive signs and they are tied to one specific market. Tune in to see which market I […]
Read Article
Corcept Therapeutics Inc (CORT) rose sharply late in trading on Tuesday after a rumor hit the street. The rumor was that the company may have received some kind of patent approval, but no details were mentioned. Nevertheless, given the strength of the upward movement, it seems clear that the market is convinced that something strongly […]
Read Article
